Effect of a Higher Dose of Alpha-1 Antitrypsin Augmentation Therapy on Lung Inflammation in Subjects With Alpha-1 Antitrypsin Deficiency
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Alpha 1-antitrypsin deficiency; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 30 May 2016 Status changed from recruiting to completed.
- 25 Sep 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.